de Figueiredo WLD, Lopes EF, Jezini DL, Marçal LN, de Assunção EN, Ribeiro Rodrigues PR, José da Mota A, de Carvalho DM, Filho SA, Lopes Botelho JB. Differential gene expression profile of multinodular goiter.
PLoS One 2022;
17:e0268354. [PMID:
35594253 PMCID:
PMC9122239 DOI:
10.1371/journal.pone.0268354]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Accepted: 04/27/2022] [Indexed: 12/24/2022] Open
Abstract
Introduction
The goiter, a neglected heterogeneous molecular disease, remains a major indication for thyroidectomies in its endemic regions.
Objectives
This study analyzed differential gene expression in surgical specimens diagnosed with multi nodular and compared the data to that of thyroid tissue without multinodular goiter from patients undergoing thyroidectomy in Manaus-AM, Brazil using RNA-seq technology.
Methodology
The transcriptome information of the surgical specimen fragments with and without multinodular goiter was accessed by Illumina HiSeq 2000 New Generation Sequencing (NGS) using the RNA-seq NEBNext® Ultra™ RNA Library Prep Kit for Illumina®—#E7530L protocol and differential gene expression analysis.
Results
Differences were found between the gene expression profiles of the diseased tissues and those of the healthy control tissues; at least 70 genes were differentially expressed. The HOTS gene was expressed only in multinodular goiter tissues (p < 0.05).
Conclusion
These results demonstrate that the gene expression profile of multinodular goiter is pro-tumoral and that HOTS can play a central role in multinodular goiter development.
Collapse